Researchers unlock immune cell contributions that could lead to new therapies for endometrial cancer



Researchers unlock immune cell contributions that could lead to new therapies for endometrial cancer

Endometrial cancer is the most common cancer of the female reproductive system. Patients who have active immune responses against cancer cells tend to have better outcomes, but much of what is known focuses on only one type of immune cell called T cells. Researchers now provide insight on the role of B cell immunity in endometrial cancer.

Materials provided by H. Lee Moffitt Cancer Center & Research Institute. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

9th December 2022

Clues found regarding tumor suppressor gene's breast cancer activity

Read more
9th December 2022

New findings on how to avert excessive weight loss from COVID-19

Read more
9th December 2022

P53 could be key to therapies for salivary gland cancer

Read more